R. Eric Davis

Medical Student

Last publication 2024 Last refreshed 2026-04-01

faculty

1 h-index 15 pubs 6 cited

Biography and Research Information

OverviewAI-generated summary

R. Eric Davis's research has investigated the mechanisms of cancer cell dormancy and resistance to therapeutic agents. His work includes studying the effects of CB-839, an inhibitor of glutaminase, on inducing reversible dormancy in lung tumor cells. Davis has also contributed to research on therapeutic strategies to overcome resistance to venetoclax in aggressive B-cell lymphomas, as indicated by his recent publications. He has collaborated with researchers from the University of Arkansas at Fayetteville and the University of Arkansas for Medical Sciences, including Ruud P.M. Dings, Eric R. Siegel, Gunnar Boysen, and Robert J. Griffin. Davis has published 15 papers with a total of 6 citations and an h-index of 1. His recent publications are from 2023 and 2024, indicating recent activity in his research pursuits.

Metrics

  • h-index: 1
  • Publications: 15
  • Citations: 6

Selected Publications

  • CB-839 induces reversible dormancy in lung tumor-cells (2024)
    6 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

26 Collaborators 1 Institution 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics